处方级联一例分析  

Analysis of prescription cascade:a case report

作　　者：黄茜[1] 陈常凤[1] 史亦丽 HUANG Xi;CHEN Chang-feng;SHI Yi-li(Department of Pharmacy,Beijing Airport Hospital,Beijing 101318,China;Department of Pharmacy,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China)

机构地区：[1]北京市顺义区空港医院药剂科,北京101318 [2]中国医学科学院北京协和医学院北京协和医院药剂科,北京100730

出　　处：《临床药物治疗杂志》2022年第5期78-79,共2页Clinical Medication Journal

摘　　要：1例90岁高血压患者因头晕就诊于基层医院,应用盐酸阿罗洛尔片3 h后出现心动过缓。对症给予硫酸阿托品注射液0.25 mg入壶,未出现不适,7 h后再次给予0.5 mg后出现排尿困难、尿潴留,提示处方级联形成。临床药师及时发现,建议停药,对症处理后好转,2 d后排尿正常。提示社区医务人员需重视处方级联,以及基层药师需要探索基于社区的药物治疗管理服务,在药物选择时注意预防处方级联,保障患者用药安全。A 90-year-old patient with hypertension went to primary hospital for dizziness.The patient developed bradycardia 3 hours after administration of Arotinolol.0.25 mg Atropine was given to the patient and discomfort was not found.0.5 mg Atropine was given again 7 hours later.The patient developed dysuria and retention of urine,suggesting a cascade of prescriptions.The clinical pharmacist promptly discovered the medication problem and advised to stop the medicine.After the symptomatic treatment,patient got improved.The micturition got recovered 2 days later.This case suggests that the medical staffs in our community should pay more attention to the prescription cascade.Pharmacists working at primary care institutions need to explore community-based drug treatment management and pay attention to the prescription cascade in order to improve medication safety.

关 键 词：盐酸阿罗洛尔 硫酸阿托品 尿潴留 处方级联 

分 类 号：R969.3[医药卫生—药理学]